Background: This study aimed to investigate the neuromuscular effects of 0.6 mg/kg rocuronium under desflurane anesthesia in patients with and without renal failure.
INTRODUCTION
Rocuronium bromide (rocuronium), a monoquaternary aminosteroid with a short onset and an intermediate duration of action, is currently one of the most commonly used neuromuscular blocking agents [1] . Although hepatic uptake and biliary excretion have been suggested to be the main mechanisms of rocuronium metabolism, a previous study has shown that 33% of rocuronium was excreted unchanged in the urine within 24 h with metabolites absent both in plasma and urine [2] . Clearance of rocuronium was reduced by 39% and the duration of the neuromuscular block due to rocuronium 0.6 mg/ kg was shown to be prolonged during propofol-based anesthesia in patients with end-stage renal failure compared to that of healthy control patients [3] .
Desflurane anesthesia significantly prolonged the duration of action of rocuronium, compared to sevoflurane or propofol anesthesia [4] . Desflurane did not lead to a deterioration of creatinine clearance in patients with preexisting renal impairment [5] . Previous studies of rocuronium in patients with renal failure were performed with isoflurane [6] [7] [8] or propofol [3, 9] as the main anesthetic agent. Thus, the aim of this study was to compare the pharmacodynamics of a bolus dose of rocuronium under desflurane anesthesia in patients with and without renal failure. 
MATERIALS AND METHODS

After obtaining Hospital Ethics Committee approval and
RESULTS
There were no important differences in sex distribution, age, weight and height of the two groups (Table 1) . Patients in the Values are mean ± SD. TOF70: recovery to a TOF ratio of 70%. Values are mean ± SD (range).
renal failure group frequently had quite severe pathology related to their renal disease including hypertension, anemia, diabetes mellitus, cardiomegaly, and pulmonary congestion. These complications were not present in the control group. Urea and creatinine plasma concentrations were significantly higher in patients with renal failure compared to those with normal renal function (P ＜ 0.001), whereas plasma electrolyte values were similar in both groups (Table 2) . Two patients in the renal failure group had potassium levels above 6 mEq/L (range 3.4 −6.3 mEq/L), while all patients in the normal renal function groups had potassium levels within normal limits. Hematocrit values were significantly lower in the patients with renal failure compared to those with normal renal function (P ＜ 0.001) ( Table 2 ).
The neuromuscular block characteristics after 0.6 mg/kg of rocuronium are given in Table 3 . The spontaneous recovery of TOF70 was not achieved in two patients with normal renal function and more surgical relaxation was needed before such recovery. Three patients with renal failure did not spontaneously reach a TOF70 until complete connection of the renal vessels. The onset time was no different between the groups.
The times to recovery of T1 to 25%, 75% and 95% and of the TOF70, and the recovery index were found to be significantly prolonged in the renal failure patients compared to those with normal renal function (P ＜ 0.001). The linear dependence of the time to TOF70 on diagnostic duration illustrated a very strong association (R 2 = 0.79, P ＜ 0.001) (Fig. 1) . A significant degree of association was found between the time to TOF70 and BUN levels (R 2 = 0.23, P = 0.038) (Fig. 2) .
However, a poor degree of association was found between the time to TOF70 and creatinine levels (R 2 = 0.01, P = 0.649) (Fig. 3) . 
DISCUSSION
We investigated the duration of action of 0.6 mg/kg rocuronium increased to 179% during desflurane anesthesia in patients with end-stage renal failure compared with that of healthy controls. We reported a very strong association between the time to TOF70 and the duration of renal failure.
Kumar et al. [12] reported the respective times after 0.6 mg/kg rocuronium during desflurane anesthesia to recovery of the first response in the TOF stimulation to 25%, 90%, TOF70 and recovery index were 36 ± 8.3 min, 54 ± 15.4 min, 66 ± 13.4 min and 14 ± 5.3 min, respectively, which corresponded with our results. Wulf and colleagues [13] found the intensity of the neuromuscular block of rocuronium to be enhanced by sevoflurane and desflurane compared with that of total intravenous anesthesia (propofol/fentanyl), whereas this therapy did not result in significant effects on the duration of or recovery from the block. Bock and colleagues [14] found that patients receiving sevoflurane, isoflurane or desflurane showed comparable slopes of the dose-response curves of rocuronium, and the curves were shifted to the left compared with those obtained during propofol anesthesia. The same study did not show sig- . At all stages of renal insufficiency, the creatinine level was a much more reliable indicator of renal function than was the BUN level because the BUN was far more likely to be affected by dietary and physiologic conditions not related to renal function [18] . We cannot demonstrate the major causes of a better association of BUN than that of creatinine with the time to TOF70. This relationship needs further study.
The renal patients in this study were undergoing renal transplantation. This may have altered the elimination characteristics of rocuronium after complete connection of renal vessels.
Three patients with renal failure were excluded because TOF70
was not spontaneously reached and was only reached upon complete connection of the renal vessels.
These results demonstrate that the neuromuscular effects of 0.6 mg/kg rocuronium under desflurane anesthesia are markedly prolonged in patients with renal failure compared to patients with normal renal function, and the effects are enhanced according to the duration of renal failure. Therefore, careful monitoring of neuromuscular transmission should be performed to prevent overdose of neuromuscular blockers in renal failure patients.
